Winston-Salem.

PositionTriad

WINSTON-SALEM -- Targacept, which was spun off from cigarette maker Reynolds American in 2000, received $500,000 from drug maker GlaxoSmithKline for identifying a chemical compound that could lead to a new smoking-cessation...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT